Whit Mayo
Stock Analyst at Leerink Partners
(2.51)
# 2,308
Out of 5,149 analysts
156
Total ratings
52.53%
Success rate
10.43%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $9.64 | +24.48% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $23.44 | -6.14% | 12 | Feb 26, 2026 | |
| EHAB Enhabit | Maintains: Market Perform | $9.5 → $14 | $13.58 | +1.62% | 3 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $235.12 | +12.28% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $19.57 | -13.13% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $294.07 | +5.42% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $1.71 | +46.20% | 5 | Mar 31, 2025 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $9.48 | +163.71% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $187.28 | +33.49% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $108.06 | -7.46% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $41.58 | -63.92% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $294.93 | +89.88% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $206.42 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $129.46 | -25.07% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $290.85 | +15.18% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $532.92 | -46.33% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $15.88 | +151.89% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $24.04 | +62.23% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.04 | -26.47% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.62 | +4,774.09% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $73.97 | +136.58% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $19.65 | -3.31% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.39 | +17.99% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $286.47 | -29.14% | 2 | May 1, 2018 |
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $9.64
Upside: +24.48%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $23.44
Upside: -6.14%
Enhabit
Feb 23, 2026
Maintains: Market Perform
Price Target: $9.5 → $14
Current: $13.58
Upside: +1.62%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $235.12
Upside: +12.28%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $19.57
Upside: -13.13%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $294.07
Upside: +5.42%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $1.71
Upside: +46.20%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $9.48
Upside: +163.71%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $187.28
Upside: +33.49%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $108.06
Upside: -7.46%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $41.58
Upside: -63.92%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $294.93
Upside: +89.88%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $206.42
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $129.46
Upside: -25.07%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $290.85
Upside: +15.18%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $532.92
Upside: -46.33%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $15.88
Upside: +151.89%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $24.04
Upside: +62.23%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.04
Upside: -26.47%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.62
Upside: +4,774.09%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $73.97
Upside: +136.58%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $19.65
Upside: -3.31%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.39
Upside: +17.99%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $286.47
Upside: -29.14%